Impact of Sarcopenia on Prognosis in Primary Hepatocellular Carcinoma Patients Treated with Transcatheter Arterial Chemoembolization: A Single Center Retrospective Study
Yaowei Bai, Jiacheng Liu, Ying Wang, Binqian Zhou, Xiaoming Liu, Xiangjun Dong, Chuansheng Zheng · Journal of Cancer · 2024
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Journal of Cancer · Ivyspring International Publisher · article · 2024
Abstract
Objective: This study aimed to investigate the prognostic effect of sarcopenia on primary hepatocellular carcinoma (HCC) patients after transcatheter arterial chemoembolization (TACE).Methods: This retrospective study enrolled 265 patients diagnosed with HCC who underwent TACE between April 2014 and February 2021.The patients were divided into two groups: the sarcopenia group (n=133) and the non-sarcopenia group (n=132).The study analyzed the differences in overall survival (OS) and progression-free survival (PFS) using Kaplan-Meier curves.The independent risk factors for OS and PFS were determined using univariate and multivariate Cox regression analysis.Based on these factors, the study constructed a prognostic risk grading system.Results: At 3 and 6 months post-TACE, the prognoses of the sarcopenia group were worse than that of the non-sarcopenia group according to the mRECIST criteria.Kaplan-Meier curves showed that the cumulative OS and PFS rate in the non-sarcopenia group were significantly higher compared to the sarcopenia group (HR=3.319,95%CI: 2.283-4.824,Log-rank P < 0.001; HR=0.631, 95%CI: 0.486-0.820,Log-rank P < 0.001).Sarcopenia, maximal tumor diameter, and AFP ≥ 200 ng/mL were independent risk factors for OS and PFS.The prognostic risk grading system based on sarcopenia, AFP ≥ 200 ng/mL, and maximal tumor diameter≥8.9 cm showed significant differences in prognosis between risk groups.Conclusion: Sarcopenia had excellent predictive value for OS and PFS in patients after TACE, and AFP ≥ 200 ng/mL and maximal tumor diameter were also independent risk factors for a poor prognosis.The prognostic risk grading system based on sarcopenia, AFP, and maximal tumor diameter had good guiding value for the prognosis of patients.
Open the resolved locator · 10.7150/jca.92976
Metadata licence: OpenAlex metadata (CC0)